Is sampling really effective in staging non-small cell lung cancer? A prospective study

Area of Science:

• Thoracic Surgery
• Oncology
• Surgical Pathology

Background:

• Accurate staging of non-small cell lung cancer (NSCLC) is crucial for treatment planning.
• The necessity of systematic nodal dissection versus mediastinal lymph node sampling for staging NSCLC requires further investigation.

Purpose of the Study:

• To evaluate the effectiveness of mediastinal lymph node sampling in accurately staging non-small cell lung cancer.
• To determine if mediastinal lymph node sampling can replace systematic nodal dissection in selected cases for lung cancer treatment.

Main Methods:

• A prospective study involving 94 patients with clinically resectable non-small cell lung cancer (stages I-IIIB).
• Surgical treatment by a single surgical team, involving initial mediastinal lymph node sampling followed by systematic nodal dissection.
• Identification of 193 mediastinal nodal stations using the American Thoracic Society lymph node map.

Main Results:

• Mediastinal lymph node sampling and systematic nodal dissection showed agreement in 94% (181/193) of investigated nodal stations.
• Disagreement between the two techniques occurred in 6% (12/193) of cases.
• The negative predictive value of mediastinal lymph node sampling was 92.8% (103/111).

Conclusions:

• Mediastinal lymph node sampling demonstrates comparable effectiveness to systematic nodal dissection for staging non-small cell lung cancer.
• A small percentage of cases may be understaged with sampling alone, potentially leading to incomplete resection.
• In cases where sampling detects N2 disease, completion with systematic nodal dissection is necessary for radical intervention.